Assessment of screening for prostate cancer using the digital rectal examination
- PMID: 2709500
- DOI: 10.1016/s0022-5347(17)41192-x
Assessment of screening for prostate cancer using the digital rectal examination
Abstract
An early detection study for prostate cancer was initiated to determine the effect of routine digital rectal examinations on the stage of prostate cancer at diagnosis. A prostate biopsy was recommended if induration, asymmetry or nodules were detected on the digital examination. During a 6-year period 4,160 examinations were performed on 2,131 men more than 45 years old. A prostate biopsy was performed on 144 men and 36 malignant tumors were detected, of which 68 per cent were clinically localized. Pelvic lymph node metastases were found in 6 per cent of the surgically staged cancer patients and in 10 per cent of the patients who had a high grade tumor. Surgical staging revealed that 50 per cent of the patients with clinical stage B disease were upstaged to stage C or D1 disease. These results suggest that mass screening programs using digital examination may not add sufficient benefit over conventional medical care to warrant the expense. Definitive proof that screening can lower the mortality rate from prostate cancer can be obtained only by a prospective randomized clinical trial.
Similar articles
-
Screening for prostate cancer in Romania.Int Urol Nephrol. 2002;34(4):503-5. doi: 10.1023/a:1025627204632. Int Urol Nephrol. 2002. PMID: 14577492
-
Early detection of prostate cancer by routine screening.JAMA. 1984 Dec 21;252(23):3261-4. JAMA. 1984. PMID: 6512929
-
Digital rectal examination to screen for prostatic cancer.Eur Urol. 1988;15(1-2):34-6. doi: 10.1159/000473390. Eur Urol. 1988. PMID: 3215234
-
Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against.Eur Urol. 1996;29 Suppl 2:24-6. doi: 10.1159/000473833. Eur Urol. 1996. PMID: 8717457 Review.
-
Digital rectal examination in the early detection of prostate cancer.Urol Clin North Am. 1990 Nov;17(4):739-44. Urol Clin North Am. 1990. PMID: 2219574 Review.
Cited by
-
Is digital screening for prostatic cancer effective?Bull N Y Acad Med. 1992 Nov;68(4):470-5. Bull N Y Acad Med. 1992. PMID: 1283361 Free PMC article. No abstract available.
-
Inosine monophosphate dehydrogenase 2 as a marker of aggressive and advanced prostate cancer.Cent European J Urol. 2018;71(4):399-403. doi: 10.5173/ceju.2018.1696. Epub 2018 Sep 24. Cent European J Urol. 2018. PMID: 30680233 Free PMC article.
-
Diffusion-weighted imaging with apparent diffusion coefficient mapping and spectroscopy in prostate cancer.Top Magn Reson Imaging. 2008 Dec;19(6):261-72. doi: 10.1097/RMR.0b013e3181aa6b50. Top Magn Reson Imaging. 2008. PMID: 19512848 Free PMC article. Review.
-
Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells.J Nanopart Res. 2009 Jun 23;12(5):1599-1608. doi: 10.1007/s11051-009-9681-3. J Nanopart Res. 2009. PMID: 22328862 Free PMC article.
-
Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.Cancer Rep (Hoboken). 2019 Aug;2(4):e1169. doi: 10.1002/cnr2.1169. Epub 2019 Apr 2. Cancer Rep (Hoboken). 2019. PMID: 32721116 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical